Replies to post #25432 on Rich Pharmaceuticals Inc. (fka RCHA)

[Scott12]

This is another great example at the vagueness you all are getting from Big Ben.

"Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology, announced today the potential for using its drug RP-323 (TPA) in the treatment of Hodgkin's lymphoma."

The word potential falls under the category as being a forward-looking statement. For all we know they may never use their drug.

It's all about selling shares.